Gliomas Completed Phase 1 / 2 Trials for Sonidegib (DB09143)

Also known as: Glioma / [M]Glioma NOS

IndicationStatusPhase
DBCOND0032593 (Gliomas)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01125800A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MBTreatment